News|Articles|September 2, 2022

COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 2, 2022

Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

US COVID-19 vaccination & booster dose status

US COVID-19 vaccination status according to the Centers for Disease Control and Prevention (CDC) as of September 1, 2022, at 6:00 AM, EDT:

Fully vaccinated plus 2 booster doses:

• Aged ≥50 years 34%

• Aged ≥65 years 41.2%

Fully vaccinated plus 1 booster dose:

• Total US population 48.5%

Fully vaccinated in key age groups:

• Total US population 67.5%

• Aged ≥5 years 71.7%

• Aged ≥65 years 92.1%

US confirmed cases of COVID-19 and deaths

Confirmed US cases of COVID-19 and related deaths according to the Johns Hopkins COVID-19 interactive map, as of September 2, 2022 at 2:21 PM, EDT.

3 states with highest number of new cases in past 28 days

• California 290 114

• Texas 248 992

• Florida 196 143

• Total US confirmed cases 94 684 605

• Total US confirmed deaths 1 047 183

Global total COVID-19 confirmed cases, deaths, vaccine doses administered:

• Cases 603 336 130

• Deaths 6 491 556 • Vaccine doses administered 12 144 301 921

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!

COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 2, 2022

US COVID-19 vaccination & booster dose status

Fully vaccinated plus 2 booster doses:

• Aged ≥50 years 34%

• Aged ≥65 years 41.2%

Fully vaccinated plus 1 booster dose:

• Total US population 48.5%

Fully vaccinated in key age groups:

• Total US population 67.5%

• Aged ≥5 years 71.7%

• Aged ≥65 years 92.1%

US confirmed cases of COVID-19 and deaths

3 states with highest number of new cases in past 28 days

• California 290 114

• Texas 248 992

• Florida 196 143

• Total US confirmed cases 94 684 605

• Total US confirmed deaths 1 047 183

Global total COVID-19 confirmed cases, deaths, vaccine doses administered:

• Cases 603 336 130

• Deaths 6 491 556 • Vaccine doses administered 12 144 301 921

Newsletter

Related Content

Hormone Therapy and Autoimmune Disease: Early Findings Raise New Questions for Postmenopausal Care

Xuezhi Daniel Jiang, MD, PhD, on Counseling Postmenopausal Women on Autoimmune Disease Risk Without Creating Hormone Therapy Phobia

Perimenopause Symptom Management is Never One-Size-Fits-All, Says Menopause Expert

Administration Anounces Landmark GLP-1 Pricing Agreement with Eli Lilly and Novo Nordisk

Oral Semaglutide 25 mg Shows Cardiometabolic Benefits Beyond Weight Loss in OASIS 4 Analysis

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Expert Perspectives on Technological Advances in Cataract Surgery

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Southern Florida Psychiatry Conference

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations

Expert Illustrations and Commentaries™: The Role of the Paracellular Pathway in the Management of Hyperphosphatemia in CKD

Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval

(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Innovations in MDS Care: Navigating New Treatment Paradigms, Breakthrough Therapies, and Emerging Clinical Evidence

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

Homing in on the Role of PSMA in Prostate Cancer – Harnessing the Power of Precision Medicine Through Imaging and Therapy to Individualize Treatment Plans

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Identifying and Treating CIDP in the Modern Era

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Breast Cancer Symposia in San Antonio

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Burst CME™: How is the Newly Approved CAR T-Cell Therapy Impacting R/R B-Cell ALL Management?

(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice

(COPE Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Rapid Reviews in Retina™: Emerging Updates from Fall 2024 - Addressing the Wealth of New Data in Treatments for nAMD and DME

Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L

Rounds with Dr Jabbour: Breaking Barriers in ALL Treatment